Using a similar strategy as illustrated in Fig. 2c, we found that knocking down MAP1B in FXS patient iPSCs differentiated neurons resulted in a significant increase in both complexity and total dendritic length, compared with controls (Fig. 8a, b, Supplementary Fig. 17a, b). The gene discussed is MAP1B; the disease is fragile X syndrome.